Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients. [PDF]
Khaleqsefat E +4 more
europepmc +1 more source
Jianpi-Huogu Prescription Repairs Nontraumatic Osteonecrosis of the Femoral Head by Inhibiting NAMPT/STK11/HMGCR/ACAT1 Axis-Mediated Lipid Production. [PDF]
Li T +8 more
europepmc +1 more source
Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study. [PDF]
Li M +7 more
europepmc +1 more source
Biological Effects of Calceolarioside A as a Natural Compound: Anti-Ovarian Cancer, Anti-Tyrosinase, and Anti-HMG-CoA Reductase Potentials with Molecular Docking and Dynamics Simulation Studies. [PDF]
Chen L, Han D, Gu C, Huang W.
europepmc +1 more source
Exploring the anti-obesity potential of Ailanthus excelsa Roxb in vitro enzymatic inhibition and computational pharmacology insights. [PDF]
Gudasi S +8 more
europepmc +1 more source
Potential antihyperlipidemic effects of myrcenol and curzerene in high-fat fed rats. [PDF]
Tahir S +9 more
europepmc +1 more source
Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals. [PDF]
Nordestgaard LT +7 more
europepmc +1 more source
PBX3-HMGCR Axis Promotes Hepatocellular Carcinoma Progression Through Enhancing De Novo Cholesterol Biosynthesis. [PDF]
Zhang X +7 more
europepmc +1 more source

